NDC 58005-307-04 - ATROPINE SULFATE
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 58005-307
- Requested NDC
- 58005-307-04
- Package NDCs from labels
- 58005-307-04
- Manufacturer
- Sparhawk Laboratories, Inc.
- Effective date
- 2017-02-01
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| ATROPINE SULFATE LA 15 MG | Sparhawk Laboratories, Inc. | 2017-02-01 | PRESCRIPTION ANIMAL DRUG LABEL |
DailyMed Dashboard NDC Coverage#
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| ATROPINE SULFATE | ACTIVE INGREDIENT | 03J5ZE7KA5 | ATROPINE SULFATE INJECTION, SOLUTION [SPARHAWK LABORATORIES, INC.] | 1 | |
| ATROPINE | ACTIVE MOIETY | 7C0697DR9I | ATROPINE SULFATE INJECTION, SOLUTION [SPARHAWK LABORATORIES, INC.] | 1 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Atropine Sulfate | ATROPINE SULFATE | REMEDYREPACK INC. | 8663ff94-8bea-4061-9fd5-3ab2e85e862e | 2026-09-04 | Warnings, Adverse reactions | 03J5ZE7KA5 |
| Atropine Sulfate | ATROPINE SULFATE | REMEDYREPACK INC. | 532aa441-92ec-42d6-862a-639f8cfe9951 | 2026-08-31 | Warnings, Adverse reactions | 03J5ZE7KA5 |
| Atropine | ATROPINE SULFATE | Gland Pharma Limited | a116af5c-ba4c-408c-9a02-4bc33772aa8d | 2026-08-03 | Warnings, Adverse reactions | 03J5ZE7KA5 |
| Diphenoxylate Hydrochloride and Atropine Sulfate | DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE | A-S Medication Solutions | f94a0189-40d2-42e0-8d2b-c9dc433faad1 | 2026-07-29 | Warnings, Adverse reactions | 03J5ZE7KA5 |
| Atropine Sulfate | ATROPINE SULFATE | Henry Schein, Inc. | 0f5b0961-efe7-42c3-898e-2f7fc7fc90b1 | 2026-07-28 | Warnings, Adverse reactions | 03J5ZE7KA5 |
| ATROPINE SULFATE | ATROPINE SULFATE | HF Acquisition Co LLC, DBA HealthFirst | 768dc21a-b7d9-144c-e053-2991aa0af889 | 2026-06-19 | Warnings, Adverse reactions | 03J5ZE7KA5 |
| Diphenoxylate Hydrochloride and Atropine Sulfate | DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE | REMEDYREPACK INC. | 3d0e2877-7a74-433f-8a31-e3e54aa9dc9f | 2026-06-10 | Warnings, Adverse reactions | 03J5ZE7KA5 |
| Diphenoxylate Hydrochloride and Atropine Sulfate | DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE | Redpharm Drug | 5342df5c-12bb-565c-e063-6294a90a4ade | 2026-06-02 | Warnings, Adverse reactions | 03J5ZE7KA5 |
| Diphenoxylate Hydrochloride and Atropine Sulfate | DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE | Bryant Ranch Prepack | bd08ed90-dd26-4629-83c0-0f75af6ebb95 | 2026-05-21 | Warnings, Adverse reactions | 03J5ZE7KA5 |
| Phenohytro | PHENOBARBITAL, HYOSCYAMINE SULFATE, ATROPINE SULFATE, AND SCOPOLAMINE HYDROBROMIDE | ATLANTIC BIOLOGICALS CORP. | a5aaf1db-1938-4073-9da4-c47f959d013e | 2026-05-19 | Warnings, Adverse reactions | 03J5ZE7KA5 |
| Atropine Sulfate | ATROPINE SULFATE | Hospira, Inc. | ad8916e7-206e-409e-2582-30d072845dd4 | 2026-05-18 | Warnings, Adverse reactions | 03J5ZE7KA5 |
| Atropine sulfate | ATROPINE SULFATE | Edenbridge Pharmaceuticals LLC. | b39f5876-5d6f-4a8f-bd24-bd4be24ff568 | 2026-05-07 | Warnings, Adverse reactions | 03J5ZE7KA5 |
| Diphenoxylate Hydrochloride and Atropine Sulfate | DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE | Preferred Pharmaceuticals Inc. | 46d5b27b-a710-4767-b308-4f673ddb354c | 2026-04-06 | Warnings, Adverse reactions | 03J5ZE7KA5 |
| Atropine Sulfate | ATROPINE SULFATE | REMEDYREPACK INC. | 46ba6000-b842-449a-8dd4-7bb9dc7a74c5 | 2026-04-03 | Warnings, Adverse reactions | 03J5ZE7KA5 |
| Motofen | DIFENOXIN AND ATROPINE SULFATE | Legacy Pharma USA Inc. | 1fa11c67-5492-469c-9475-6bfa0e5e9ff8 | 2026-03-23 | Warnings, Adverse reactions | 03J5ZE7KA5 |
| atropine sulfate | ATROPINE SULFATE | Alcon Laboratories, Inc. | c8093125-ed1a-4eb6-9c81-52c5c7376481 | 2026-03-13 | Warnings, Adverse reactions | 03J5ZE7KA5 |
| Liver Tonic II | BOLDO, CARDUUS MARIANUS, CURCUMA LONGA, ECHINACEA (ANGUSTIFOLIA), TARAXACUM OFFICINALE MAGNESIA PHOSPHORICA, GALLBLADDER (BOVINE), HEPAR BOVINE, AMMI VISNAGA, ATROPINUM SULPHURICUM, CHELIDONIUM MAJUS, LEPTANDRA VIRGINICA, PODOPHYLLINUM | BioActive Nutritional, Inc. | b3bdb177-e2d7-4fd6-b0b7-8174fc53fb6c | 2026-03-11 | Warnings | 03J5ZE7KA5 |
| Atropine | ATROPINE SULFATE | Apotex Corp. | 127a7e32-a150-01d6-a66a-b7708d85809f | 2026-03-10 | Warnings, Adverse reactions | 03J5ZE7KA5 |
| Lomotil | DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE | Pfizer Laboratories Div Pfizer Inc | f170584a-1072-4fd7-b1dc-6756703483b9 | 2026-02-23 | Warnings, Adverse reactions | 03J5ZE7KA5 |
| Diphenoxylate Hydrochloride and Atropine Sulfate | DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE | Mylan Pharmaceuticals Inc. | 83bcc2fb-6fb0-4f0e-8e66-592d327684ec | 2026-02-23 | Warnings, Adverse reactions | 03J5ZE7KA5 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.